Research
Drug Science publishes peer reviewed research, reports, and articles to provide clear, evidence-based information without political or commercial interference.
Update What you have helped us achieve so far Our medical cannabis registry, Project Twenty21, was originally designed to run until the end of 2021 (hence the name). As you will know from your own life during the pandemic, the last two years have been full of challenges and obstacles. Project…
- January 6, 2022
Authors Rayyan Zafar, Anne Schlag, Lawrence Phillips, David J Nutt Published December 15, 2021 We previously reported on the legalisation of medical cannabis in the UK which was catalysed by a young boy, Alfie Dingley, suffering from a rare form of epilepsy that was treatable through medical cannabis. Alfie’s case was…
- December 15, 2021
Authors Michael A. White, Nicholas R. Burns Published December 13, 2021 The development of drug driving policies should rest on sound epidemiological evidence as to the crash risks of driving after using psychoactive drugs. The findings from individual studies of the increased risk of crashing from the acute use of cannabis…
- December 14, 2021
Get Project Twenty21 Updates via Email To mark the end of the year that is our namesake, we're proud to announce that we've reached 2000 patients contributing their data to Project Twenty21. In a recent article for Cannabis Health, our Head of Development, David Horn, reflects on the last two years and…
- December 14, 2021
The British Paediatric Neurology Association (BPNA) recently produced new guidance on the prescription of cannabis medicines for children with epilepsy. However, the Medical Cannabis Clinicians Society (UKMCCS) and Drug Science fundamentally disagree with this guidance. Expert clinicians from both organisations have produced a critique to provide commentary, evidence and further crucial information…
- December 6, 2021
Authors Ben Houghton, Alexis Bailey, Christos Kouimtsidis, Theodora Duka, Caitlin Notley Published November 25, 2021 Background Opioid-related deaths are at record levels in the UK and contribute to over half of all drug-related deaths. The prevalence of psychiatric disorders within people who uses substances is known to be considerably higher than…
- November 29, 2021